减重代谢外科在中国——发展与展望

doi:10.16139/j.1007-9610.2020.05.002

摘要/Abstract

中图分类号:

R589.2

蔡超强, 孙许龙, 朱晒红. 减重代谢外科在中国——发展与展望[J]. 外科理论与实践, 2020, 25(05): 364-368.

CA Chaogiang, SUN Xulong, ZHU Shaihong. Bariatric and metabolic surgery in China: recent developments and future prospects[J]. Journal of Surgery Concepts & Practice, 2020, 25(05): 364-368.

参考文献 41

[1]	Henrikson V. Can small bowel resection be defended for therapy for obesity?[J]. Obes Surg, 1994, 4(1):54-55.
[2]	Kremen AJ, Linner JH, Nelson CH. An experimental evaluation of the nutritional importance of proximal and distal small intestine[J]. Ann Surg, 1954, 140(3):439-448.
[3]	Mason EE, Ito C. Gastric bypass in obesity[J]. Surg Clin North Am, 1967, 47(6):1345-1351.
[4]	杨忠魁, 赵晓宇, 杨洪木, 等. Payne改良法治疗肥胖病一例[J]. 中华外科杂志, 1984, 22(3):143.
[5]	郑成竹, 胡兵, 胡明根, 等. 腹腔镜可调节捆扎带胃减容术治疗肥胖症[J]. 中国实用外科杂志, 2003, 23(10): 634-635.
[6]	NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants[J]. Lancet, 2016, 387(10026):1377-1396.
[7]	顾景范. 《中国居民营养与慢性病状况报告(2015)》解读[J]. 营养学报, 2016, 38(6):525-529.
[8]	Lesser IA, Yew AC, Mackey DC, et al. A cross-sectional analysis of the association between physical activity and visceral adipose tissue accumulation in a multiethnic cohort[J]. J Obes, 2012, 2012:703941.
[9]	Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications[J]. Nat Rev Endocrinol, 2018, 14(2):88-98. doi: 10.1038/nrendo.2017.151 pmid: 29219149
[10]	Shai I, Jiang R, Manson JE, et al. Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study[J]. Diabetes Care, 2006, 29(7):1585-1590.
[11]	Ji G, Li P, Li W, et al. The effect of bariatric surgery on Asian patients with type 2 diabetes mellitus and body mass index <30 kg/m²: a systematic review and meta-analysis[J]. Obes Surg, 2019, 29(8):2492-2502.
[12]	Tuomi T, Santoro N, Caprio S, et al. The many faces of diabetes: a disease with increasing heterogeneity[J]. Lancet, 2014, 383(9922):1084-1094.
[13]	Livingston EH. Inadequacy of BMI as an indicator for bariatric surgery[J]. JAMA, 2012, 307(1):88-89. doi: 10.1001/jama.2011.1950 pmid: 22215170
[14]	Hägg S, Fall T, Ploner A, et al. Adiposity as a cause of cardiovascular disease: a Mendelian randomization study[J]. Int J Epidemiol, 2015, 44(2):578-586.
[15]	Wu J, Gong L, Li Q, et al. A novel visceral adiposity index for prediction of type 2 diabetes and pre-diabetes in Chinese adults: a 5-year prospective study[J]. Rep, 2017, 7(1):13784.
[16]	Zeitler P, Hirst K, Pyle L, et al. A clinical trial to maintain glycemic control in youth with type 2 diabetes[J]. N Engl J Med, 2012, 366(24):2247-2256.
[17]	Durkin N, Desai AP. What Is the evidence for paediatric/adolescent bariatric surgery?[J]. Curr Obes Rep, 2017, 6(3):278-285.
[18]	El Chaar M, King K, Al-Mardini A, et al. Thirty-day outcomes of bariatric surgery in adolescents: a first look at the MBSAQIP database[J]. Obes Surg, 2020 Jul 28,1-6. doi: 10.1007/s11695-020-04866-w doi: 10.1007/s11695-020-04866-w URL
[19]	Inge TH, Laffel LM, Jenkins TM, et al. Comparison of surgical and medical therapy for type 2 diabetes in severely obese adolescents[J]. JAMA Pediatr, 2018, 172(5):452-460.
[20]	Roth AE, Thornley CJ, Blackstone RP. Outcomes in bariatric and metabolic surgery: an updated 5-year review[J]. Curr Obes Rep, 2020, 9(3):380-389. doi: 10.1007/s13679-020-00389-8 pmid: 32607822
[21]	Frimel TN, Sinacore DR, Villareal DT. Exercise attenua-tes the weight-loss-induced reduction in muscle mass in frail obese older adults[J]. Med Sci Sports Exerc, 2008, 40(7):1213-1219.
[22]	Molero J, Olbeyra R, Vidal J, et al. A propensity score cohort study on the long-term safety and efficacy of sleeve gastrectomy in patients older than age 60[J]. J Obes, 2020, 2020(2):8783260.
[23]	Jakobsen GS, Småstuen MC, Sandbu R, et al. Association of bariatric surgery vs medical obesity treatment with long-term medical complications and obesity-related comorbidities[J]. JAMA, 2018, 319(3):291-301. doi: 10.1001/jama.2017.21055 pmid: 29340680
[24]	Hu G, Qiao Q, Tuomilehto J. The metabolic syndrome and cardiovascular risk[J]. Curr Diabetes Rev, 2005, 1(2):137-143
[25]	Benotti PN, Wood GC, Carey DJ, et al. Gastric bypass surgery produces a durable reduction in cardiovascular disease risk factors and reduces the long-term risks of congestive heart failure[J]. J Am Heart Assoc, 2017, 6(5): e005126.
[26]	Tschoner A, Sturm W, Gelsinger C, et al. Long-term effects of weight loss after bariatric surgery on functional and structural markers of atherosclerosis[J]. Obesity (Silver Spring), 2013, 21(10):1960-1965.
[27]	Moussa O, Ardissino M, Heaton T, et al. Effect of bariatric surgery on long-term cardiovascular outcomes: a nationwide nested cohort study[J]. Eur Heart J, 2020, 41(28):2660-2667. doi: 10.1093/eurheartj/ehaa069 pmid: 32188981
[28]	Jiskoot G, Benneheij SH, Beerthuizen A, et al. A three-component cognitive behavioural lifestyle program for preconceptional weight-loss in women with polycystic ovary syndrome (PCOS): a protocol for a randomized controlled trial[J]. Reprod Health, 2017, 14(1):34. doi: 10.1186/s12978-017-0295-4 pmid: 28264692
[29]	Saboor Aftab SA, Kumar S, Barber TM. The role of obesity and type 2 diabetes mellitus in the development of male obesity-associated secondary hypogonadism[J]. Clin Endocrinol (Oxf), 2013, 78(3):330-337.
[30]	Li L, Liu DW, Yan HY, et al. Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies[J]. Obes Rev, 2016, 17(6):510-519. doi: 10.1111/obr.12407 pmid: 27020692
[31]	Lassailly G, Caiazzo R, Buob D, et al. Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients[J]. Gastroenterology, 2015, 149(2):379-388.
[32]	潘艺嘉, 汪志红. 减重手术治疗肥胖患者非酒精性脂肪性肝病的研究进展[J]. 现代医药卫生, 2016, 32(8): 1176-1178.
[33]	Peterli R, Wölnerhanssen BK, Peters T, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial[J]. JAMA, 2018, 319(3):255-265. doi: 10.1001/jama.2017.20897 pmid: 29340679
[34]	Salminen P, Helmiö M, Ovaska J, et al. Effect of laparoscopic sleeve gastrectomy vs. laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial[J]. JAMA, 2018, 319(3):241-254. doi: 10.1001/jama.2017.20313 pmid: 29340676
[35]	Sha Y, Huang X, Ke P, et al. Laparoscopic Roux-en-Y gastric bypass versus sleeve gastrectomy for type 2 diabetes mellitus in nonseverely obese patients: a systematic review and meta-analysis of randomized controlled trials[J]. Obes Surg, 2020, 30(5):1660-1670.
[36]	Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies[J]. Lancet, 2009, 373(9669):1083-1096. doi: 10.1016/S0140-6736(09)60318-4 pmid: 19299006
[37]	Espinet Coll E, Nebreda Durán J, López-Nava Breviere G, et al. Multicenter study on the safety of bariatric endoscopy[J]. Rev Esp Enferm Dig, 2017, 109(5):350-357.
[38]	Celio AC, Wu Q, Kasten KR, et al. Comparative effectiveness of Roux-en-Y gastric bypass and sleeve gastrectomy in super obese patients[J]. Surg Endosc, 2017, 31(1):317-323. doi: 10.1007/s00464-016-4974-y pmid: 27287899
[39]	闫晓芳, 史静琤, 程文炜, 等. 中老年人因超重和肥胖导致的自付医疗费用研究[J]. 中国卫生统计, 2019, 36(1):22-27.
[40]	Mäklin S, Malmivaara A, Linna M, et al. Cost-utility of bariatric surgery for morbid obesity in Finland[J]. Br J Surg, 2011, 98(10):1422-1429. doi: 10.1002/bjs.7640 pmid: 21887777
[41]	Alsumali A, Eguale T, Bairdain S, et al. Cost-effectiveness analysis of bariatric surgery for morbid obesity[J]. Obes Surg, 2018, 28(8):2203-2214. doi: 10.1007/s11695-017-3100-0 pmid: 29335933

减重代谢外科在中国——发展与展望

Bariatric and metabolic surgery in China: recent developments and future prospects

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 41

相关文章 15

编辑推荐

Metrics

本文评价

[1]	林崴仪, 戈成旺, 唐枭伟, 等. 阿克曼嗜黏液菌外膜蛋白 1100 促进糖尿病大鼠创面愈合 [J]. 组织工程与重建外科杂志, 2023, 19(4): 358-.
[2]	王伟铭. 糖尿病肾脏疾病肾性贫血认识与管理中国专家共识（2023年版）解读[J]. 内科理论与实践, 2023, 18(03): 137-140.
[3]	毕礼明, 王朝晖. 糖尿病肾病发病机制研究进展[J]. 内科理论与实践, 2023, 18(03): 201-205.
[4]	张小月, 王伟铭. 盐皮质激素受体拮抗剂在糖尿病肾病治疗中的研究进展[J]. 内科理论与实践, 2023, 18(03): 206-210.
[5]	黄先觉, 姚琪远. 微创手术助推肥胖与代谢性疾病的外科治疗[J]. 外科理论与实践, 2023, 28(03): 215-219.
[6]	高玉莲, 冯耘, 倪磊. 糖尿病人群中耐药革兰阴性菌血流感染的研究进展[J]. 内科理论与实践, 2023, 18(02): 124-127.
[7]	张梦潇, 韦晓, 张少红, 陈国芳, 刘超. 生长分化因子15：减重治疗的新靶点[J]. 内科理论与实践, 2023, 18(02): 128-130.
[8]	张音, 沈宏华, 许轶明, 任蕾, 李骏, 吴顺军, 凌小楠. 肌少症合并腹型肥胖对住院老年人肌力及躯体功能的影响[J]. 内科理论与实践, 2023, 18(02): 76-82.
[9]	中华医学会内分泌学分会. 老年与儿童青少年糖尿病人群新型冠状病毒感染临床应对指南[J]. 内科理论与实践, 2023, 18(01): 10-12.
[10]	张梦潇, 孙烁烁, 韦晓, 张少红, 陈国芳, 刘超. 生酮饮食诱导db/db小鼠肝脏脂肪沉积[J]. 内科理论与实践, 2023, 18(01): 56-63.
[11]	卜凡玉　郭晓峰　徐鹏　王进　薛明宇　潘筱云. 抗生素骨水泥联合其他综合干预措施治疗糖尿病足骨髓炎[J]. 组织工程与重建外科杂志, 2022, 18(4): 328-.
[12]	缪雅, 刘丽丽, 侯田志超, 严青华, 庞怡, 吴春晓, 程旻娜, 施燕, 黎衍云, 田景琰. 上海糖尿病前期人群恶性肿瘤发病风险分析[J]. 内科理论与实践, 2022, 17(06): 435-440.
[13]	阮铭, 侯田志超, 王海燕, 黎衍云, 周冰心, 包超慧, 秦洁洁, 王宇光, 方海, 朱伟嵘, 田景琰. 糖尿病前期“治未病”的几何深度学习与计算医学研究展望[J]. 内科理论与实践, 2022, 17(06): 475-481.
[14]	秦雪, 郭华, 张云云, 崔小川. C1q肿瘤坏死因子相关蛋白3与代谢相关疾病的研究进展[J]. 内科理论与实践, 2022, 17(06): 482-485.
[15]	叶雅芬, 杨颖, 韩峻峰. 脂肪组织衰老的细胞学改变及其分子机制研究进展[J]. 诊断学理论与实践, 2022, 21(05): 650-654.